VIVS VivoSim Labs, Inc. - Common Stock

NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗
$0,28
Prezzo · Ago 19, 2026
Fondamentali al Ago 12, 2026

VIVS Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo
$0.28
Capitalizzazione di Mercato
$797.4K
P/E (TTM)
-0.1
EPS (TTM)
$-5.35
Ricavi (TTM)
$131.0K
Rendimento div.
ROE
-294.8%
D/E Debito/Patrimonio
Intervallo 52 sett.
$0 – $5

VIVS Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $131.0K
10-point trend, -96.9%
2017-03-31 2026-03-31
EPS $-5.35
5-point trend, -305.3%
2022-03-31 2026-03-31
Flusso di cassa libero $-11M
5-point trend, +64.5%
2017-03-31 2026-03-31
Margini -10567.2%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica
Tendenza 5 anni
VIVS
Mediana dei peer
P/E (TTM)
5-point trend, +99.2%
-0.1
P/S (TTM)
5-point trend, -99.8%
6.1
48.2
P/B
5-point trend, -100.3%
-0.7
1.5
Price / FCF (Prezzo / FCF)
5-point trend, +100.0%
-0.1

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica
Tendenza 5 anni
VIVS
Mediana dei peer
Operating Margin (Margine Operativo)
5-point trend, -861.5%
-8768.7%
Net Profit Margin (Margine di Profitto Netto)
5-point trend, -1062.6%
-10567.2%
-7380.2%
ROA
5-point trend, -123.4%
-125.6%
-95.1%
ROE
5-point trend, -377.4%
-294.8%
-119.3%
ROIC
1045.4%

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica
Tendenza 5 anni
VIVS
Mediana dei peer
Current Ratio (Rapporto corrente)
5-point trend, -78.0%
2.4
3.0
Quick Ratio
5-point trend, -82.8%
1.8

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica
Tendenza 5 anni
VIVS
Mediana dei peer
Revenue YoY (Ricavi YoY)
5-point trend, -91.3%
-9.0%
Revenue CAGR 3Y (CAGR Ricavi 3Y)
5-point trend, -91.3%
-29.3%

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica
Tendenza 5 anni
VIVS
Mediana dei peer
EPS (Diluted) (EPS (Diluito))
5-point trend, -305.3%
$-5.35

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica
Tendenza 5 anni
VIVS
Mediana dei peer

VIVS Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

VENDI 7 analisti
  • Acquisto forte 0 0,0%
  • Compra 0 0,0%
  • Mantieni 4 57,1%
  • Vendi 1 14,3%
  • Vendita forte 2 28,6%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media
0.54%
Periodo EPS Actual EPS Stimato Sorpresa
31 Marzo 2025 $-2.21 $-0.19 -2.0%
31 Dicembre 2024 $-2.29 $-2.57 0.28%
30 Settembre 2024 $-1.68 $-3.18 1.5%
30 Giugno 2024 $-2.76 $-4.04 1.3%
31 Marzo 2024 $-3.48 $-5.14 1.7%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
VIVS $4M -0.3 -9.0% -10567.2% -294.8%
MBRX
HCWB -0.1 -97.9% -14677.1% -586.8% 20.0%
REVB
SILO $5M -0.7 0.00% -5863.5% -75.3% 38.6%
CRIS $13M -1.7 -13.4% -80.3% 177.9%
RNAZ -0.1
ONCO $2M -0.1 -67.7% -1721.0% -129.5% 77.6%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 17
Dati annuali Conto Economico per VIVS
Metrica Tendenza 202620252024202320222021202020192018201720162015
Revenue 12-point trend, -77.1% $131.0K $144.0K $109.0K $370.0K $2M $0 $2M $3M $5M $4M $1M $571.0K
Cost of Revenue 9-point trend, +0.00 $0 $5.0K · · · $0 $328.0K $482.0K $1M $956.0K $0 $0
R&D Expense 12-point trend, -67.6% $4M $5M $5M $9M $3M $1M $5M $15M $18M $20M $18M $13M
SG&A Expense 12-point trend, -58.6% $7M $8M $10M $9M $10M $16M $18M $15M $21M $22M $22M $18M
Operating Expenses 12-point trend, -62.4% $12M $13M $15M $18M $13M $17M $24M $30M $40M $43M $40M $31M
Operating Income 12-point trend, +62.1% $-11M $-13M $-15M $-18M $-11M $-17M $-21M $-27M $-35M $-39M $-39M $-30M
Interest Expense 3-point trend, -100.0% · · · · · · · · · $0 $0 $1.0K
Interest Income 12-point trend, +734.4% $267.0K $140.0K $405.0K $454.0K $8.0K $15.0K $594.0K $705.0K $478.0K $198.0K $88.0K $32.0K
Other Non-op 12-point trend, -1194.9% $-2M $10M $417.0K $474.0K $25.0K $6.0K $2M $0 $-12.0K $0 $0 $215.0K
Pretax Income 2-point trend, -456.8% $-14M $-2M · · · · · · · · · ·
Income Tax 12-point trend, +2000.00 $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K $3.0K $2.0K $23.0K $3.0K $0
Net Income 12-point trend, +54.0% $-14M $-2M $-15M $-17M $-11M $-17M $-19M $-27M $-35M $-38M $-39M $-30M
EPS (Basic) 5-point trend, -305.3% $-5.35 $-1.70 $-19.25 $-1.98 $-1.32 · · · · · · ·
EPS (Diluted) 5-point trend, -305.3% $-5.35 $-1.70 $-19.25 $-1.98 $-1.32 · · · · · · ·
Shares (Basic) 5-point trend, -70.3% 2,588,327 1,463,609 762,076 8,713,032 8,703,596 · · · · · · ·
Shares (Diluted) 5-point trend, -70.3% 2,588,327 1,463,609 762,076 8,713,032 8,703,596 · · · · · · ·
EBITDA 7-point trend, +62.2% $-11M · · · $-11M · · $-26M $-34M $-37M $-38M $-30M
Stato Patrimoniale 24
Dati annuali Stato Patrimoniale per VIVS
Metrica Tendenza 202620252024202320222021202020192018201720162015
Cash & Equivalents 12-point trend, -90.0% $5M $11M $3M $15M $29M $37M $27M $36M $44M $63M $62M $50M
Short-term Investments · · · · $0 · · · · · · ·
Receivables 12-point trend, +32000.00 $32.0K $30.0K $33.0K $152.0K $0 $0 $111.0K $503.0K $883.0K $647.0K $259.0K $0
Inventory 9-point trend, -100.0% · $0 $297.0K $0 · · $0 $490.0K $842.0K $550.0K $334.0K $66.0K
Prepaid Expense 12-point trend, -47.2% $557.0K $789.0K $705.0K $889.0K $858.0K $1M $851.0K $1M $1M $1M $968.0K $1M
Other Current Assets 4-point trend, -100.0% $0 $12.0K $4.0K $69.0K · · · · · · · ·
Current Assets 12-point trend, -87.1% $7M $12M $4M $17M $30M $38M $28M $39M $47M $65M $64M $51M
PP&E (Net) 12-point trend, -89.9% $206.0K $419.0K $669.0K $902.0K $662.0K $381.0K $0 $2M $3M $4M $4M $2M
PP&E (Gross) 12-point trend, -36.3% $2M $2M $2M $2M $2M $1M $415.0K $6M $7M $7M $6M $3M
Accum. Depreciation 12-point trend, +73.1% $2M $2M $1M $1M $1M $1M $415.0K $5M $4M $3M $2M $1M
Other Non-current Assets 7-point trend, +868.9% · · · · · $1M $123.0K $138.0K $152.0K $121.0K $134.0K $106.0K
Total Assets 12-point trend, -86.2% $7M $15M $6M $20M $33M $40M $28M $41M $50M $69M $68M $53M
Accounts Payable 12-point trend, -26.4% $1M $2M $627.0K $331.0K $415.0K $281.0K $720.0K $628.0K $464.0K $1M $787.0K $1M
Accrued Liabilities 12-point trend, -56.5% $981.0K $1M $727.0K $3M $489.0K $440.0K $1M $3M $3M $4M $2M $2M
Current Liabilities 12-point trend, -41.5% $3M $4M $2M $4M $1M $721.0K $2M $4M $5M $6M $4M $5M
Capital Leases 8-point trend, +0.00 $0 $421.0K $888.0K $1M $2M $0 · $0 · · · $0
Total Liabilities 12-point trend, +77.0% $8M $4M $3M $5M $3M $721.0K $2M $4M $5M $7M $5M $5M
Common Stock 12-point trend, -96.3% $3.0K $2.0K $1.0K $9.0K $9.0K $9.0K $7.0K $124.0K $111.0K $104.0K $92.0K $82.0K
Retained Earnings 12-point trend, -191.1% $-356M $-342M $-340M $-325M $-308M $-296M $-279M $-261M $-234M $-199M $-161M $-122M
Treasury Stock 7-point trend, +0.00 $0 $1.0K $1.0K $1.0K $1.0K $1.0K $0 · · · · ·
AOCI 6-point trend, +0.00 · · $0 $2.0K $0 · · · $0 $-11.0K $0 ·
Stockholders' Equity 12-point trend, -102.3% $-1M $10M $4M $15M $30M $39M $27M $36M $45M $62M $62M $49M
Liabilities + Equity 12-point trend, -86.2% $7M $15M $6M $20M $33M $40M $28M $41M $50M $69M $68M $53M
Shares Outstanding 12-point trend, -96.5% 2,894,519 1,898,068 839,814 8,716,906 8,710,627 8,670,492 6,527,905 124,015,429 111,032,957 104,551,466 104,551,466 81,536,724
Flusso di cassa 12
Dati annuali Flusso di cassa per VIVS
Metrica Tendenza 202620252024202320222021202020192018201720162015
D&A 12-point trend, -54.4% $215.0K $266.0K $280.0K $293.0K $142.0K $41.0K $1M $980.0K $1M $1M $815.0K $472.0K
Stock-based Comp 4-point trend, -1.7% · · · · · · · · $7M $7M $9M $7M
Other Non-cash 7-point trend, -6.3% $3M · · · $3M · · $5M $-2M $721.0K $-164.0K $3M
Operating Cash Flow 12-point trend, +44.8% $-11M $-9M $-15M $-12M $-8M $-13M $-15M $-20M $-29M $-29M $-29M $-20M
CapEx 12-point trend, -100.0% $0 $13.0K $42.0K $396.0K $409.0K $405.0K $0 $79.0K $226.0K $1M $2M $2M
Investing Cash Flow 9-point trend, +132.2% $94.0K $9M $816.0K $-966.0K $-409.0K $-393.0K $747.0K $-76.0K $-292.0K · · ·
Stock Issued 9-point trend, -48.7% $5M $9M $1M $0 $251.0K $24M $5M $13M $9M · · ·
Stock Repurchased 3-point trend, +0.00 · · · · $0 $1.0K $0 · · · · ·
Net Stock Activity 3-point trend, -63.9% $5M · · · $251.0K · · $13M · · · ·
Financing Cash Flow 9-point trend, -56.0% $4M $9M $1M $0 $205.0K $24M $5M $13M $10M · · ·
Net Change in Cash 12-point trend, -418.4% $-6M $8M $-12M $-13M $-9M $10M $-9M $-7M $-19M $660.0K $12M $2M
Free Cash Flow 7-point trend, +48.7% $-11M · · · $-9M · · $-20M $-29M $-31M $-31M $-21M
Redditività 7
Dati annuali Redditività per VIVS
Metrica Tendenza 202620252024202320222021202020192018201720162015
Operating Margin 7-point trend, -65.3% -8768.7% · · · -765.3% · · -882.4% -766.3% -911.9% -2605.7% -5305.9%
Net Margin 7-point trend, -100.6% -10567.2% · · · -763.2% · · -861.7% -756.1% -908.9% -2601.2% -5268.3%
Pretax Margin -10565.6% · · · · · · · · · · ·
EBITDA Margin 7-point trend, -64.7% -8604.6% · · · -755.8% · · -850.7% -738.7% -884.8% -2550.8% -5223.3%
ROA 7-point trend, -116.5% -125.6% · · · -31.3% · · -58.9% -58.5% -56.2% -63.7% -58.0%
ROE 7-point trend, -375.1% -294.8% · · · -33.0% · · -65.9% -65.1% -61.7% -69.6% -62.0%
ROIC 1045.4% · · · · · · · · · · ·
Liquidità e Solvibilità 3
Dati annuali Liquidità e Solvibilità per VIVS
Metrica Tendenza 202620252024202320222021202020192018201720162015
Current Ratio 7-point trend, -77.9% 2.4 · · · 21.4 · · 10.3 10.0 10.8 14.2 10.8
Quick Ratio 7-point trend, -82.8% 1.8 · · · 20.7 · · 9.9 9.6 10.5 13.9 10.5
Interest Coverage · · · · · · · · · · · -30297.0
Efficienza 3
Dati annuali Efficienza per VIVS
Metrica Tendenza 202620252024202320222021202020192018201720162015
Asset Turnover 7-point trend, +8.2% 0.0 · · · 0.0 · · 0.1 0.1 0.1 0.0 0.0
Inventory Turnover 3-point trend, -66.5% · · · · · · · 0.7 1.5 2.2 · ·
Receivables Turnover 5-point trend, -63.1% 4.2 · · · · · · 4.5 6.0 9.3 11.5 ·
Per Azione 5
Dati annuali Per Azione per VIVS
Metrica Tendenza 202620252024202320222021202020192018201720162015
Book Value / Share 7-point trend, -163.6% $-0.38 · · · $3.47 · · $0.29 $0.40 $0.60 $0.67 $0.60
Revenue / Share $0.05 · · · · · · · · · · ·
Cash Flow / Share $-4.18 · · · · · · · · · · ·
Cash / Share 7-point trend, +182.2% $1.74 · · · $3.29 · · $0.29 $0.39 $0.60 $0.67 $0.61
EPS (TTM) 12-point trend, -531.5% $-5.35 $-1.70 $-19.25 $-1.98 $-1.32 $1.24 $1.24 $1.24 $1.24 $1.24 $1.24 $1.24
Tassi di Crescita 2
Dati annuali Tassi di Crescita per VIVS
Metrica Tendenza 202620252024202320222021202020192018201720162015
Revenue YoY 4-point trend, +88.0% -9.0% 32.1% -70.5% -75.3% · · · · · · · ·
Revenue CAGR 3Y 2-point trend, +46.0% -29.3% -54.2% · · · · · · · · · ·
Valutazione (TTM) 10
Dati annuali Valutazione (TTM) per VIVS
Metrica Tendenza 202620252024202320222021202020192018201720162015
Revenue TTM 12-point trend, -77.1% $131.0K $144.0K $109.0K $370.0K $2M $0 $2M $3M $5M $4M $1M $571.0K
Net Income TTM 12-point trend, +54.0% $-14M $-2M $-15M $-17M $-11M $-17M $-19M $-27M $-35M $-38M $-39M $-30M
Market Cap 7-point trend, -100.0% $4M · · · $393M · · $29.47B $27.45B $79.79B $48.12B $69.27B
P/E 12-point trend, -100.0% -0.3 -1.3 -0.6 -13.3 -34.2 93.3 79.4 191.6 199.4 615.5 420.0 685.2
P/S 7-point trend, -100.0% 31.6 · · · 262.0 · · 9532.9 5962.9 18863.8 32446.2 121319.8
P/B 7-point trend, -100.3% -3.8 · · · 13.0 · · 811.8 615.6 1279.5 773.8 1422.6
P / Tangible Book 5-point trend, -98.4% · 0.4 34.6 14.9 13.0 25.6 · · · · · ·
P / Cash Flow 7-point trend, +100.0% -0.4 · · · -46.5 · · -1446.2 -951.2 -2734.1 -1638.4 -3534.2
P / FCF 7-point trend, +100.0% -0.4 · · · -44.3 · · -1440.6 -943.8 -2612.8 -1528.4 -3280.3
Earnings Yield 12-point trend, -249520.0% -374.1% -75.9% -155.7% -7.5% -2.9% 1.1% 1.3% 0.52% 0.50% 0.16% 0.24% 0.15%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico
2026-03-312025-03-312024-03-312023-03-312022-03-31
Ricavi $131.0K$144.0K$109.0K$370.0K$2M
Margine Operativo % -8768.7%-765.3%
Utile netto $-14M$-2M$-15M$-17M$-11M
EPS Diluito $-5.35$-1.70$-19.25$-1.98$-1.32
Stato Patrimoniale
2026-03-312025-03-312024-03-312023-03-312022-03-31
Rapporto corrente 2.421.4
Quick Ratio 1.820.7
Flusso di cassa
2026-03-312025-03-312024-03-312023-03-312022-03-31
Flusso di cassa libero $-11M$-9M

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 27 filer · $111K totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
7 (+4 vs trimestre precedente) 3 (-4 vs trimestre precedente) 3 (-2 vs trimestre precedente) 3 (+2 vs trimestre precedente) +29K

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
VANGUARD GROUP INC $27.822 15.371 25,15% Azioni
GEODE CAPITAL MANAGEMENT, LLC $20.032 18.720 18,11% Azioni
RENAISSANCE TECHNOLOGIES LLC $19.795 18.500 17,89% Azioni
VANGUARD CAPITAL MANAGEMENT LLC $16.447 15.371 14,87% Azioni
BlackRock, Inc. $12.644 11.817 11,43% Azioni
VANGUARD FIDUCIARY TRUST CO $7.493 7.003 6,77% Azioni
Tower Research Capital LLC (TRC) $5.616 5.249 5,08% Azioni
SBI Securities Co., Ltd. $236 221 0,21% Azioni
Larson Financial Group LLC $178 166 0,16% Azioni
ALBION FINANCIAL GROUP /UT $171 159 0,15% Azioni
MORGAN STANLEY $52 49 0,05% Azioni
OSAIC HOLDINGS, INC. $50 49 0,05% Azioni
HRT FINANCIAL LP $19 18.319 0,02% Azioni
Caitong International Asset Management Co., Ltd $18 17 0,02% Azioni
IFG Advisory, LLC $15 14 0,01% Azioni
UBS Group AG $11 10 0,01% Azioni
Integrated Wealth Concepts LLC $9 8 0,01% Azioni
WELLS FARGO & COMPANY/MN $3 3 0,00% Azioni
Rockefeller Capital Management L.P. $2 2 0,00% Azioni
Golden State Wealth Management, LLC $2 2 0,00% Azioni
Federation des caisses Desjardins du Quebec $2 2 0,00% Azioni
Activest Wealth Management $2 2 0,00% Azioni
First Command Advisory Services, Inc. $1 1 0,00% Azioni
HARBOUR INVESTMENTS, INC. $1 1 0,00% Azioni
Hilton Head Capital Partners, LLC $1 1 0,00% Azioni
FNY Investment Advisers, LLC $0 200 0,00% Azioni
ROYAL BANK OF CANADA $0 1 0,00% Azioni

Insider aziendali 31 insider · 14 dirigenti · 17 direttori

Insider Ruolo Ultima attività Azioni possedute Acquisti 12m Vendite 12m Netto 12m
Taylor Crouch CEO & President 18 Agosto 2020 F 125.144 0 0 $0
Craig Kussman Chief Financial Officer 18 Agosto 2020 F 221.743 0 0 $0
Barry D Michaels Chief Financial Officer 24 Agosto 2015 A 86.808 0 0 $0
Murphy Keith EXECUTIVE CHAIRMAN 27 Gennaio 2026 A 26.053 0 0 $0
Amar Akhtar Sethi Chief Scientific Officer 25 Novembre 2025 A 0 0 $0
Tony Serge Lialin Chief Commercial Officer 11 Agosto 2025 A 0 0 $0
Jeffrey N. Miner Chief Scientific Officer 31 Agosto 2022 A 0 0 $0
Thomas E Jurgensen General Counsel & Secretary 31 Agosto 2022 A 0 0 $0
Jennifer Bush General Counsel & Secretary 18 Agosto 2020 F 192.758 0 0 $0
Steven George Hughes Chief Medical Officer 16 Agosto 2019 S 138.484 0 0 $0
Paul Gallant General Manager 16 Agosto 2019 F 191.335 0 0 $0
Sharon Collins Presnell Chief Scientific Officer 16 Novembre 2018 F 280.993 0 0 $0
Eric David CSO & EVP Pre-Clinical Dev 16 Novembre 2017 F 876.609 0 0 $0
Michael Renard EVP of Commercial Operations 04 Giugno 2015 A 50.000 0 0 $0
David Gobel Direttore 27 Gennaio 2026 A 15.000 0 1 $-7.316
Alison Tjosvold Milhous Direttore 27 Gennaio 2026 A 19.899 0 0 $0
Douglas Jay Cohen Direttore 27 Gennaio 2026 A 20.732 0 0 $0
Adam K Stern Direttore 27 Gennaio 2026 A 19.899 0 0 $0
Vaidehi Joshi Direttore 07 Agosto 2024 A 58.821 0 0 $0
David Shapiro Direttore 05 Settembre 2019 A 0 0 $0
Richard E Maroun Direttore 05 Settembre 2019 A 15.000 0 0 $0
Carolyn Beaver Direttore 05 Settembre 2019 A 0 0 $0
Kirk Malloy Direttore 05 Settembre 2019 A 7.500 0 0 $0
Mark Kessel Direttore 05 Settembre 2019 A 15.000 0 0 $0
Robert Baltera Jr. Direttore 26 Luglio 2018 A 146.006 0 0 $0
James T Glover Direttore 26 Luglio 2018 A 17.500 0 0 $0
Tamar D Howson Direttore 26 Luglio 2018 A 7.500 0 0 $0
Richard A. Heyman Direttore 20 Agosto 2015 A 0 0 $0
Andras Forgacs Direttore 18 Ottobre 2012 A 0 0 $0
Chris Heberlig 15 Settembre 2020 A 0 0 $0
Kevin Kimberlin 27 Settembre 2012 J 0 0 $0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduto da 1 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo Peso Unità Aggiornato al Fonte
VXF · VANGUARD INDEX FUNDS 0,00% 15.371 SH 08 Agosto 2026 Giornaliero